Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Grey matter volume loss is associated with specific clinical motor signs in Huntington's disease.

Coppen EM, Jacobs M, van den Berg-Huysmans AA, van der Grond J, Roos RAC.

Parkinsonism Relat Disord. 2018 Jan;46:56-61. doi: 10.1016/j.parkreldis.2017.11.001. Epub 2017 Nov 2.

PMID:
29128164
2.

Early grey matter changes in structural covariance networks in Huntington's disease.

Coppen EM, van der Grond J, Hafkemeijer A, Rombouts SA, Roos RA.

Neuroimage Clin. 2016 Oct 12;12:806-814. eCollection 2016.

3.

Early atrophy of pallidum and accumbens nucleus in Huntington's disease.

van den Bogaard SJ, Dumas EM, Acharya TP, Johnson H, Langbehn DR, Scahill RI, Tabrizi SJ, van Buchem MA, van der Grond J, Roos RA; TRACK-HD Investigator Group.

J Neurol. 2011 Mar;258(3):412-20. doi: 10.1007/s00415-010-5768-0. Epub 2010 Oct 9.

4.

Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study.

Douaud G, Gaura V, Ribeiro MJ, Lethimonnier F, Maroy R, Verny C, Krystkowiak P, Damier P, Bachoud-Levi AC, Hantraye P, Remy P.

Neuroimage. 2006 Oct 1;32(4):1562-75. Epub 2006 Jul 27.

PMID:
16875847
5.

Regional specificity of brain atrophy in Huntington's disease.

Halliday GM, McRitchie DA, Macdonald V, Double KL, Trent RJ, McCusker E.

Exp Neurol. 1998 Dec;154(2):663-72.

PMID:
9878201
6.

Cognitive Control, Learning, and Clinical Motor Ratings Are Most Highly Associated with Basal Ganglia Brain Volumes in the Premanifest Huntington's Disease Phenotype.

Misiura MB, Lourens S, Calhoun VD, Long J, Bockholt J, Johnson H, Zhang Y, Paulsen JS, Turner JA, Liu J, Kara B, Fall E; PREDICT-HD Investigators & Working Group.

J Int Neuropsychol Soc. 2017 Feb;23(2):159-170. doi: 10.1017/S1355617716001132.

7.

Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat.

Ruocco HH, Bonilha L, Li LM, Lopes-Cendes I, Cendes F.

J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):130-5. Epub 2007 Jul 5.

PMID:
17615168
8.

Regional atrophy associated with cognitive and motor function in prodromal Huntington disease.

Aylward EH, Harrington DL, Mills JA, Nopoulos PC, Ross CA, Long JD, Liu D, Westervelt HK, Paulsen JS; PREDICT-HD Investigators and Coordinators of the Huntington Study Group.

J Huntingtons Dis. 2013;2(4):477-89. doi: 10.3233/JHD-130076.

9.

Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study.

Peinemann A, Schuller S, Pohl C, Jahn T, Weindl A, Kassubek J.

J Neurol Sci. 2005 Dec 15;239(1):11-9. Epub 2005 Sep 26.

PMID:
16185716
10.

Cross-sectional and longitudinal voxel-based grey matter asymmetries in Huntington's disease.

Minkova L, Gregory S, Scahill RI, Abdulkadir A, Kaller CP, Peter J, Long JD, Stout JC, Reilmann R, Roos RA, Durr A, Leavitt BR, Tabrizi SJ, Klöppel S; TRACK-HD Investigators.

Neuroimage Clin. 2017 Oct 25;17:312-324. doi: 10.1016/j.nicl.2017.10.023. eCollection 2018.

11.

Prefrontal cortex volume reduction on MRI in preclinical Huntington's disease relates to visuomotor performance and CAG number.

Gómez-Ansón B, Alegret M, Muñoz E, Monté GC, Alayrach E, Sánchez A, Boada M, Tolosa E.

Parkinsonism Relat Disord. 2009 Mar;15(3):213-9. doi: 10.1016/j.parkreldis.2008.05.010. Epub 2008 Jul 15.

PMID:
18632301
12.

Gray matter atrophy in presymptomatic Huntington's patients.

Király A, Kincses ZT, Szabó N, Tóth E, Csete G, Faragó P, Vécsei L.

Ideggyogy Sz. 2016 Jul 30;69(7-8):261-267. doi: 10.18071/isz.69.0261.

PMID:
29465891
13.

Shape analysis of subcortical nuclei in Huntington's disease, global versus local atrophy--results from the TRACK-HD study.

van den Bogaard SJ, Dumas EM, Ferrarini L, Milles J, van Buchem MA, van der Grond J, Roos RA.

J Neurol Sci. 2011 Aug 15;307(1-2):60-8. doi: 10.1016/j.jns.2011.05.015. Epub 2011 May 31.

14.

Automated differentiation of pre-diagnosis Huntington's disease from healthy control individuals based on quadratic discriminant analysis of the basal ganglia: the IMAGE-HD study.

Georgiou-Karistianis N, Gray MA, Domínguez D JF, Dymowski AR, Bohanna I, Johnston LA, Churchyard A, Chua P, Stout JC, Egan GF.

Neurobiol Dis. 2013 Mar;51:82-92. doi: 10.1016/j.nbd.2012.10.001. Epub 2012 Oct 13.

PMID:
23069680
15.

Motor network structure and function are associated with motor performance in Huntington's disease.

Müller HP, Gorges M, Grön G, Kassubek J, Landwehrmeyer GB, Süßmuth SD, Wolf RC, Orth M.

J Neurol. 2016 Mar;263(3):539-49. doi: 10.1007/s00415-015-8014-y. Epub 2016 Jan 13.

PMID:
26762394
16.

Cerebellar abnormalities in Huntington's disease: a role in motor and psychiatric impairment?

Rees EM, Farmer R, Cole JH, Haider S, Durr A, Landwehrmeyer B, Scahill RI, Tabrizi SJ, Hobbs NZ.

Mov Disord. 2014 Nov;29(13):1648-54. doi: 10.1002/mds.25984. Epub 2014 Aug 13.

PMID:
25123926
17.

Apathy and atrophy of subcortical brain structures in Huntington's disease: A two-year follow-up study.

Baake V, Coppen EM, van Duijn E, Dumas EM, van den Bogaard SJA, Scahill RI, Johnson H, Leavitt B, Durr A, Tabrizi SJ, Craufurd D, Roos RAC; Track-HD investigators.

Neuroimage Clin. 2018 Mar 27;19:66-70. doi: 10.1016/j.nicl.2018.03.033. eCollection 2018.

18.

Basal ganglia-cortical structural connectivity in Huntington's disease.

Novak MJ, Seunarine KK, Gibbard CR, McColgan P, Draganski B, Friston K, Clark CA, Tabrizi SJ.

Hum Brain Mapp. 2015 May;36(5):1728-40. doi: 10.1002/hbm.22733. Epub 2015 Jan 30.

PMID:
25640796
19.

Evaluation of subcortical grey matter abnormalities in patients with MRI-negative cortical epilepsy determined through structural and tensor magnetic resonance imaging.

Peng SJ, Harnod T, Tsai JZ, Ker MD, Chiou JC, Chiueh H, Wu CY, Hsin YL.

BMC Neurol. 2014 May 14;14:104. doi: 10.1186/1471-2377-14-104.

20.

Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease.

Henley SM, Wild EJ, Hobbs NZ, Scahill RI, Ridgway GR, Macmanus DG, Barker RA, Fox NC, Tabrizi SJ.

J Neurol. 2009 Feb;256(2):203-12. doi: 10.1007/s00415-009-0052-x. Epub 2009 Mar 5.

PMID:
19266143

Supplemental Content

Support Center